Author

Tiara Wolf

University of South FloridaORCID 0009-0000-4274-9843Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Assay:metabolomics· 1 Assay:proteomics· 1

Frequent Co-Authors

Eleni Markoutsa· 2 shared Jennifer GuerguesiD· 2 shared Karthick MayilsamyiD· 2 shared Kristina Tosi· 2 shared Parthvi Bharatkumar Patel· 2 shared Ryan J. GreeniD· 2 shared Sashank Bikkasani· 2 shared Shyam MohapatraiD· 2 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

Eleni Markoutsa

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

NeuroscienceMolecular TherapyPeer-reviewedOct 1, 2026

Dendrimer Delivered shRNA Targeting the CCL20-CCR6 Axis Suppresses Complement-Mediated Microglial Synaptic Pruning and Ameliorates Chronic Neuroinflammation After Repetitive Traumatic Brain Injury

Karthick Mayilsamy, Parthvi Bharatkumar Patel, Ryan J. Green…·Subhra Mohapatra

This study identifies the CCL20-CCR6 axis as a driver of chronic neuroinflammation after rTBI and shows that shRNA targeting this axis reduces synaptic loss and improves behavioral outcomes.

DOI 10.1016/j.ymthe.2026.10.002

mouseexperimental assay

𝕏 PostBluesky

Cancer BiologybioRxivPreprintAug 27, 2026

CCL20-CCR6 Signaling as a Prognostic Biomarker and Therapeutic Target in Temozolomide-Resistant Glioblastoma

Ryan J. Green, Karthick Mayilsamy, Erin Anglin…·Subhra Mohapatra

This study identifies CCL20-CCR6 signaling as a prognostic biomarker and therapeutic target in temozolomide-resistant glioblastoma, showing that its inhibition enhances treatment response and induces tumor cell death.

DOI 10.64898/2026.08.26.746721

mouseproteomics

𝕏 PostBluesky